Daily Slim
Natural health product licensed in Canada
- Licence holder
- Canadian Nutraceuticals Distributors Inc
- NPN or DIN-HM
- 80053107
- Status
- Inactive licence
- Licence date
- 14 August 2014
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Chrome: up to 200 µg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 25 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026.
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Lepidium meyenii Walp.: L'absence d'alcaloïdes doit être démontrée par des rapports d'analyse.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Magnolia officinalis Rehder & E.H.Wilson: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 1,3,7-Triméthylxanthine Source : Caféine | 50 mg | Not calculated |
| Camellia sinensis Source : Camellia sinensis - feuille Extraction ratio : 1.5:1 Dry plant equivalent : 450 mg Potency : 50 % Epigallocatechin 3-gallate | 300 mg | Not calculated |
| Camellia sinensis Source : Camellia sinensis - feuille Potency : 1 % Caffeine | Not specified | Not calculated |
| Punica granatum Source : Punica granatum, Fruit | 20 mg | Not calculated |
| Paullinia cupana Source : Paullinia cupana - Graine Extraction ratio : 3:1 Dry plant equivalent : 135 mg Potency : 17 mg Caffeine | 45 mg | Not calculated |
| 3,7-dihydro-3,7-diméthyl-1H-purine-2,6-dione Source : Theobroma cacao - Graine | 40 mg | Not calculated |
| 3,7-dihydro-3,7-diméthyl-1H-purine-2,6-dione Source : Théobromine | 40 mg | Not calculated |
| L-Tyrosine Source : L-Tyrosine | 30 mg | Not calculated |
| Lepidium meyenii Source : Lepidium meyenii - Hypocotyle Extraction ratio : 4:1 Dry plant equivalent : 100 mg Potency : 0.6 % Macamides | 25 mg | Not calculated |
| Prégna-4,17-diène-3,16-dione Source : Guggulsterone | 40 mg | Not calculated |
| Prégna-4,17-diène-3,16-dione Source : Fruit Resin | 40 mg | Not calculated |
| Magnolia officinalis Source : Écorce (tige) Extraction ratio : 4:1 Dry plant equivalent : 100 mg Potency : 65 % Honokiol | 25 mg | Not calculated |
| Magnolia officinalis Source : Écorce (tige) Potency : 25 % Magnolol | Not specified | Not calculated |
| Chrome Source : Pidolate chromique | 100 mcg | 200 µg |
| L-théanine Source : Camellia sinensis - feuille | 30 mg | Not calculated |
| L-théanine Source : L-Théanine | 30 mg | Not calculated |
| Lagerstroemia speciosa Source : Lagerstroemia speciosa - feuille Extraction ratio : 24:1 Dry plant equivalent : 480 mg Potency : 1 % Corosolic acid | 20 mg | Not calculated |
| Caralluma fimbriata Source : Plante entière Extraction ratio : 20:1 Dry plant equivalent : 900 mg | 45 mg | Not calculated |
| Glucomannane Source : Amorphophallus konjac - tubercule | 20 mg | Not calculated |
Non-medicinal ingredients
Gélatine, Silice, Acide stéarique, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
A factor in the maintenance of good health. Provides support for healthy glucose metabolism. Helps the body to metabolize carbohydrates and fats. To be used with a program of reduced intake of dietary calories and increased physical activity to help in weight management.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80053107
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.